Porter KE, Turner NA (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123:255–278. https://doi.org/10.1016/j.pharmthera.2009.05.002
Talman V, Ruskoaho H (2016) Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res 365:563–581. https://doi.org/10.1007/s00441-016-2431-9
Article CAS PubMed PubMed Central Google Scholar
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7:11–20. https://doi.org/10.1016/j.cmet.2007.10.002
Article CAS PubMed Google Scholar
Luczak ED, Wu Y, Granger JM, Joiner MA, Wilson NR, Gupta A, Umapathi P, Murphy KR, Reyes Gaido OE, Sabet A et al (2020) Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy. Nat Commun 11:4416. https://doi.org/10.1038/s41467-020-18165-6
Article CAS PubMed PubMed Central Google Scholar
Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368:eaaw5473. https://doi.org/10.1126/science.aaw5473
DeNicola GM, Cantley LC (2015) Cancer’s fuel choice: new flavors for a picky eater. Mol Cell 60:514–523. https://doi.org/10.1016/j.molcel.2015.10.018
Article CAS PubMed PubMed Central Google Scholar
Kashihara T, Mukai R, Oka SI, Zhai P, Nakada Y, Yang Z, Mizushima W, Nakahara T, Warren JS, Abdellatif M et al (2022) YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. J Clin Invest 132:e150595. https://doi.org/10.1172/JCI150595
Rees ML, Subramaniam J, Li Y, Hamilton DJ, Frazier OH, Taegtmeyer H (2015) A PKM2 signature in the failing heart. Biochem Biophys Res Commun 459:430–436. https://doi.org/10.1016/j.bbrc.2015.02.122
Article CAS PubMed PubMed Central Google Scholar
Wang T, Marquardt C, Foker J (1976) Aerobic glycolysis during lymphocyte proliferation. Nature 261:702–705. https://doi.org/10.1038/261702a0
Article CAS PubMed Google Scholar
Bernard K, Logsdon NJ, Ravi S, Xie N, Persons BP, Rangarajan S, Zmijewski JW, Mitra K, Liu G, Darley-Usmar VM et al (2015) Metabolic reprogramming is required for myofibroblast contractility and differentiation. J Biol Chem 290:25427–25438. https://doi.org/10.1074/jbc.M115.646984
Article CAS PubMed PubMed Central Google Scholar
Zhao X, Kwan JYY, Yip K, Liu PP, Liu FF (2020) Targeting metabolic dysregulation for fibrosis therapy. Nat Rev Drug Discov 19:57–75. https://doi.org/10.1038/s41573-019-0040-5
Article CAS PubMed Google Scholar
Im MJ, Freshwater MF, Hoopes JE (1976) Enzyme activities in granulation tissue: energy for collagen synthesis. J Surg Res 20:121–125. https://doi.org/10.1016/0022-4804(76)90108-6
Article CAS PubMed Google Scholar
Opie LH (1990) Myocardial ischemia–metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther 4:777–790. https://doi.org/10.1007/BF00051275
Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu RM, Bernard K, Thannickal VJ, Liu G (2015) Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med 192:1462–1474. https://doi.org/10.1164/rccm.201504-0780OC
Article CAS PubMed PubMed Central Google Scholar
Wu R, Smeele KM, Wyatt E, Ichikawa Y, Eerbeek O, Sun L, Chawla K, Hollmann MW, Nagpal V, Heikkinen S et al (2011) Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury. Circ Res 108:60–69. https://doi.org/10.1161/CIRCRESAHA.110.223115
Article CAS PubMed Google Scholar
Manzano A, Rosa JL, Ventura F, Pérez JX, Nadal M, Estivill X, Ambrosio S, Gil J, Bartrons R (1998) Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3). Cytogenet Cell Genet 83:214–217. https://doi.org/10.1159/000015181
Article CAS PubMed Google Scholar
Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L (2004) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J 381:561–579. https://doi.org/10.1042/BJ20040752
Article CAS PubMed PubMed Central Google Scholar
Schoors S, De Bock K, Cantelmo AR, Georgiadou M, Ghesquière B, Cauwenberghs S, Kuchnio A, Wong BW, Quaegebeur A, Goveia J et al (2014) Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab 19:37–48. https://doi.org/10.1016/j.cmet.2013.11.008
Article CAS PubMed Google Scholar
Houddane A, Bultot L, Novellasdemunt L, Johanns M, Gueuning MA, Vertommen D, Coulie PG, Bartrons R, Hue L, Rider MH (2017) Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes. Cell Signal 34:23–37. https://doi.org/10.1016/j.cellsig.2017.02.019
Article CAS PubMed Google Scholar
Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 7:6183–6187. https://doi.org/10.1074/jbc.M110978200
Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, Suñer C, Bartrons R, Mendez R, Fernandez M (2020) CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis. Gastroenterology 159:273–288. https://doi.org/10.1053/j.gastro.2020.03.008
Article CAS PubMed Google Scholar
Herrero-Mendez A, Almeida A, Fernández E, Maestre C, Moncada S, Bolaños JP (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11:747–752. https://doi.org/10.1038/ncb1881
Article CAS PubMed Google Scholar
Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445–1453. https://doi.org/10.1161/CIRCRESAHA.110.223925
Article CAS PubMed PubMed Central Google Scholar
Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH (1993) Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88:2849–2861. https://doi.org/10.1161/01.cir.88.6.2849
Article CAS PubMed Google Scholar
Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, Maher TM, Tzouvelekis A, Ryerson CJ (2021) Idiopathic pulmonary fibrosis: disease mechanisms and drug development. Pharmacol Ther 222:107798. https://doi.org/10.1016/j.pharmthera.2020.107798
Frantz S, Hu K, Adamek A, Wolf J, Sallam A, Maier SK, Lonning S, Ling H, Ertl G, Bauersachs J (2008) Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol 103:485–492. https://doi.org/10.1007/s00395-008-0739-7
Article CAS PubMed Google Scholar
Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127–2138. https://doi.org/10.1161/CIRCULATIONAHA.107.704197
Article CAS PubMed Google Scholar
Fillmore N, Mori J, Lopaschuk GD (2014) Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br J Pharmacol 171:2080–2090. https://doi.org/10.1111/bph.12475
Article CAS PubMed PubMed Central Google Scholar
Yu H, Zhu J, Chang L, Liang C, Li X, Wang W (2021) 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model. Life Sci 272:119206. https://doi.org/10.1016/j.lfs.2021.119206
Chen ZT, Gao QY, Wu MX, Wang M, Sun RL, Jiang Y, Guo Q, Guo DC, Liu CY, Chen SX et al (2021) Glycolysis inhibition alleviates cardiac fibrosis after myocardial infarction by suppressing cardiac fibroblast activation. Front Cardiovasc Med 8:701745. https://doi.org/10.3389/fcvm.2021.701745
Henderson J, O’Reilly S (2021) The emerging role of metabolism in fibrosis. Trends Endocrinol Metab 32:639–653. https://doi.org/10.1016/j.tem.2021.05.003
Article CAS PubMed Google Scholar
de Paz-Lugo P, Lupiáñez JA, Meléndez-Hevia E (2018) High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. Amino Acids 50:1357–1365. https://doi.org/10.1007/s00726-018-2611-x
Article CAS PubMed PubMed Central Google Scholar
Savolainen ER, Leo MA, Timpl R, Lieber CS (1984) Acetaldehyde and lactate stimulate collagen synthesis of cultured baboon liver myofibroblasts. Gastroenterology 87:777–787
Article CAS PubMed Google Scholar
Donthi RV, Ye G, Wu C, McClain DA, Lange AJ, Epstein PN (2004) Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. J Biol Chem 279:48085–48090. https://doi.org/10.1074/jbc.M405510200
Article CAS PubMed Google Scholar
Wang Q, Donthi RV, Wang J, Lange AJ, Watson LJ, Jones SP, Epstein PN (2008) Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia. Am J Physiol Heart Circ Physiol 294:H2889–H2897. https://doi.org/10.1152/ajpheart.91501.2007
Article CAS PubMed Google Scholar
Zeng H, Pan T, Zhan M, Hailiwu R, Liu B, Yang H, Li P (2022) Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. Signal Transduct Target Ther 7:303. https://doi.org/10.1038/s41392-022-01097-6
Article CAS PubMed PubMed Central Google Scholar
Li
留言 (0)